[Federal Register Volume 64, Number 101 (Wednesday, May 26, 1999)]
[Notices]
[Pages 28499-28500]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-13333]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices: Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting:
NAME: Advisory Committee on Immunization Practices (ACIP).
TIMES AND DATES:
8:45 a.m.-5:30 p.m., June 16, 1999.
8 a.m.-3 p.m., June 17, 1999.
PLACE: Atlanta Marriott North Central, 2000 Century Boulevard, NE,
Atlanta, Georgia 30345-3377.
STATUS: Open to the public, limited only by the space available.
Purpose
The Committee is charged with advising the Director, CDC, on the
appropriate uses of immunizing agents. In addition, under 42 U.S.C.
Sec. 1396s, the Committee is mandated to establish and periodically
review and, as appropriate, revise the list of vaccines for
administration to vaccine-eligible children through the Vaccines for
Children (VFC) program, along with schedules regarding the appropriate
periodicity, dosage, and contraindications applicable to the vaccines.
Matters To Be Discussed
The agenda will include updates from the Food and Drug
Administration; update from the National Center for Infectious
Diseases; the National Immunization Program; the Vaccine Injury
Compensation Program; the National Vaccine Program; the adult
immunization working group; the general recommendations working group;
issues related to transition to an
[[Page 28500]]
all-IPV schedule; revision of hepatitis B recommendations; consolidated
Vaccines for Children resolution for hepatitis B vaccine;
recommendation for use of pneumococcal conjugate vaccine; revaccination
with pneumococcal polysaccharide vaccine; pneumococcal polysaccharide
vaccine in adults with HIV infection; update on influenza; American
Academy of Family Physicians recommendation for universal influenza
vaccination starting at age 50 years; status of immunization of bone
marrow transplant (BMT) recipients publication; discussion on vaccines
related to bioterrorism; teaching immunization for medical education
(TIME) project; recommendations for nursing home immunization: a HCFA/
CDC collaboration; cost-effectiveness and economic analysis of
immunization compared to other health interventions; electronic
updating of ACIP recommendations; and Institute of Medicine report on
priorities for vaccines development. Other matters of relevance among
the committee's objectives may be discussed.
Agenda items are subject to change as priorities dictate.
CONTACT PERSON FOR MORE INFORMATION: John R. Livengood, M.D., Director,
Division of Epidemiology and Surveillance, National Immunization
Program, CDC, 1600 Clifton Road, NE, M/S E-61, Atlanta, Georgia 30333,
telephone 404/639-8254.
The Director, Management Analysis and Services office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Dated: May 20, 1999.
Carolyn J. Russell
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 99-13333 Filed 5-25-99; 8:45 am]
BILLING CODE 4163-18-P
